NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
09/21/2024
Back to search
Official data from USPTO
DATACELERATE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
DATACELERATE
ST13
US500000087537995Class
35, 42
Filing
87537995
Registration
5556840
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
20
Latest update
05/13/2025
Trademark type
Word
Nice classes
35, 42
Filing date
07/21/2017
Registration date
09/04/2018
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/21/2024
Last transaction
05/13/2025
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
05/07/2018
First use in commerce
05/07/2018
Drawing code
4
Owner type
03
Owner location
West Conshohocken, PA
Examiner
GLASSER, CARYN
Current location
Historical data usage
Holders and representatives
Holders
TransCelerate Biopharma, Inc.
Representatives
Jason M. Vogel KILPATRICK TOWNSEND & STOCKTON LLP
Technical classification
Nice Classes
Class 35Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Business consulting and management in the fields of medicinepharmaceuticalsclinical and preclinical trialsmanagement and compilation of computerized databases in the field of clinical and preclinical trials for business purposes; providing an on-line database providing business information in the fields of medicinepharmaceuticalsclinical and preclinical trials; business consulting and management in the fields of medicinepharmaceuticalsclinical and preclinical trialsclinical and preclinical data and regulatory submission management on behalf of medicalbiopharmaceutical and biotechnology companies to assist them with clinical researchclinical trials and applications for drug approval
Class 42
Providing medical and scientific research information in the fields of medicinepharmaceuticalsclinical and preclinical trials; providing an on-line searchable database in the fields of medicinepharmaceuticalsclinical and preclinical trials for scientific research purposes
Publications
History of USPTO decisions and trademark events.
20 publications found
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
09/21/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/21/2024
E815
TEAS SECTION 8 & 15 RECEIVED
03/18/2024
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
09/04/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
09/04/2018
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
08/02/2018
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
08/01/2018
SUPC
STATEMENT OF USE PROCESSING COMPLETE
07/23/2018
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
07/23/2018
IUAF
USE AMENDMENT FILED
06/28/2018
EISU
TEAS STATEMENT OF USE RECEIVED
06/28/2018
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
01/23/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/28/2017
PUBO
PUBLISHED FOR OPPOSITION
11/28/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/08/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/20/2017
DOCK
ASSIGNED TO EXAMINER
10/20/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/27/2017
NWAP
NEW APPLICATION ENTERED
07/25/2017
Continuous trademark protection
Get notified about every new filing that threatens DATACELERATE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.